Open AccessCadazolid vs Vancomycin for the Treatment of Clostridioides difficile Infection: Systematic Review with Meta-analysis
Author(s) -
Muhammad Aziz,
Simcha Weissman,
Rawish Fatima,
Sabih Rajani,
Eid Albert,
Ali Nawras
Publication year - 2020
Publication title -
current clinical pharmacology
Language(s) - English
Resource type - Journals
eISSN - 2212-3938
pISSN - 1574-8847
DOI - 10.2174/1574884714666190802124301
Subject(s) - medicine , vancomycin , clostridioides , meta analysis , randomized controlled trial , adverse effect , medline , population , cochrane library , antibiotics , clinical trial , staphylococcus aureus , microbiology and biotechnology , environmental health , biology , bacteria , political science , law , genetics
Current guidelines recommend the use of vancomycin for the initial treatment of Clostridioides difficile Infection (CDI). Cadazolid, an experimental drug, has been utilized and compared in several studies with varying results.